Posted in | News | Molybdenum | Tungsten

Woulfe Mining Completes Stage 2 Drilling at Sangdong

Woulfe Mining said that it had completed the second phase of drilling at its Sangdong Tungsten-Molybdenum Project. The indicated resource at the mine has been increased 2.75 times as per the exploration program and will give the mine a life of ten years.

The President and Chief Executive Officer of Woulfe Mining, Brian Wesson said that the drilling programs had been successful and produced a significant upgraded in the indicated resource. The proving up of over 10 years of mining resources to accommodate the mining of 1.2 million per annum from above the valley floor (above 2 level) took the project forward a large step as it provided sufficient ore for the feasibility he added.

The resources update was a result of a combination of the new compliant phase 2 drilling results and further compilation of detailed historical geological and mining data as per a company statement. It added that the work had concentrated on developing more detailed models of the three skarn zones from both drill data and additional historical geological mapping. The statement mentioned that additional Intermediate alteration mineralisation were defined between the two thinner skarn zones, the F2 and F3 zones, that go to make up the footwall zone.

Mr Wesson also said that the feasibility study is running three months late due to the drilling and the metallurgical test work which was moved to China. Woulfe was focused on reconfirming the recoveries and looking to optimize the flow sheet using new age Chinese technology that had been developed over the last 20 years as the world’s largest APT supplier. Feasibility was due for release at the end of the quarter he added.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Woulfe Mining Completes Stage 2 Drilling at Sangdong. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=5831.

  • MLA

    Scanlon, Joel. "Woulfe Mining Completes Stage 2 Drilling at Sangdong". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=5831>.

  • Chicago

    Scanlon, Joel. "Woulfe Mining Completes Stage 2 Drilling at Sangdong". AZoMining. https://www.azomining.com/News.aspx?newsID=5831. (accessed November 21, 2024).

  • Harvard

    Scanlon, Joel. 2019. Woulfe Mining Completes Stage 2 Drilling at Sangdong. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=5831.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.